Mar 20, 2020   SOURCE: PR NewsWire

Colonoscopy Bowel Preparation Drugs Market to Surpass US$ 2.4 Billion, Globally, by the End of 2027 - Coherent Market Insights

SEATTLE, March 20, 2020 /PRNewswire/ -- According to Coherent Market Insights, the global colonoscopy bowel preparation drugs market was valued at US$ 1,574.9 million in 2018 and is expected to exhibit a CAGR of 4.9% over the forecast period (2019-2027).

https://mma.prnewswire.com/media/902389/Coherent_Market_Insights_Logo.jpg

Key Trends and Analysis of the Colonoscopy Bowel Preparation Drugs Market:

Key trends in the market include rising prevalence of colorectal cancer and increasing adoption of growth strategies such as acquisitions, collaborations, and product launches by the market players.

The increasing incidence of chronic gastrointestinal disorders such as colorectal cancer is expected to drive growth of the global colonoscopy bowel preparation drugs market during the forecast period. For instance, according to the World Health Organization 2020 statistics, globally, colorectal cancer is the third most commonly diagnosed cancer in males and the second in females, with around 1.8 million new cases of colorectal cancer diagnosed in 2018 and almost 861,000 deaths occurred in 2018.

Request for Sample PDF copy @ https://www.coherentmarketinsights.com/insight/request-sample/3641

Several market players are focused on product launches, which is expected to propel the market growth. For instance, in September 2018, Salix Pharmaceuticals, Ltd., an operating division of Bausch Health Companies Inc., launched PLENVU, the first and only 1 liter PEG bowel cleansing preparation for colonoscopies in the U.S.

Moreover, increasing adoption of partnerships and acquisition strategies by market players is expected to propel the market growth over the forecast period. For instance, in February 2019, Bausch Health Companies Inc. acquired certain assets of Synergy Pharmaceuticals Inc., a company focusing on the development of drugs to treat gastrointestinal disorders. As a result of this acquisition, it expanded the gastrointestinal product portfolio of Bausch Health Companies Inc. and its presence in the global market.

Key Market Takeaways:

    --  The global colonoscopy bowel preparation drugs market is expected to
        exhibit a CAGR of 4.9% during the forecast period (2019-2027), owing to
        rising prevalence of colorectal cancer. For instance, according to the
        World Health Organization 2020 statistics, globally, colorectal cancer
        is the third most commonly diagnosed cancer in males and the second in
        females, with around 1.8 million new cases of colorectal cancer
        diagnosed in 2018 and almost 861,000 deaths occurred in 2018.
    --  Key players are focused on adopting growth strategies such as product
        launches, collaborations, and acquisitions for enhancing their product
        offerings in the potential market, which in turn is expected to propel
        the market growth over the forecast period. For instance, in February
        2020, Norgine B.V. entered into an exclusive license and distribution
        agreement with Faes Farma S.A., for the distribution and
        commercialization of PLENVU, a colon cleansing preparation, in Latin
        America.

Key players operating in the global colonoscopy bowel preparation drugs market include--

Ferring B.V., Bayer AG, Braintree, Bausch Health Companies Inc., and Norgine B.V.

Buy this Report Now @ https://www.coherentmarketinsights.com/insight/buy-now/3641

Market Segmentations:

    --  Global Colonoscopy Bowel Preparation Drugs Market, By Drug Type:
        --  Isosmotic Agents
            --  High-volume Polyethylene Glycol Preparations
            --  Sulfate-free PEG-ELS
            --  Low-volume PEG Preparations
        --  Hyposmotic Agents
        --  Hyperosmotic Agents
            --  Oral sodium Sulfate
            --  Magnesium Citrate
            --  Sodium Phosphate
        --  Combination Agents
            --  Sodium Picosulfate/Magnesium Citrate
            --  Sodium Sulfate and SF-PEG-ELS
    --  Global Colonoscopy Bowel Preparation Drugs Market, By Distribution
        Channel:
        --  Hospitals Pharmacies
        --  Retail Pharmacies
        --  Others
    --  Global Colonoscopy Bowel Preparation Drugs Market, By Region:
        --  North America
                --  U.S.
                --  Canada
        --  Latin America
                --  Brazil
                --  Mexico
                --  Argentina
                --  Rest of Latin America
        --  Europe
                --  Germany
                --  U.K.
                --  France
                --  Italy
                --  Spain
                --  Russia
                --  Rest of Europe
        --  Asia Pacific
                --  China
                --  India
                --  Japan
                --  Australia
                --  South Korea
                --  ASEAN
                --  Rest of Asia Pacific
        --  Middle East
                --  GCC
                --  Israel
                --  Rest of Middle East
        --  Africa
                --  South Africa
                --  Central Africa
                --  North Africa

Did not find what you were looking for? Here are some other topics might be of your interest:

LYSOSOMAL STORAGE DISEASES THERAPEUTICS MARKET

The deficiency of enzymes that causes a specific disease condition called lysosomal storage disease includes diseases such as Fabry Disease, Gaucher disease, lysosomal acid lipase deficiency, mucopolysaccharidosis, Hunter syndrome, and Pompe disease. Enzyme replacement therapy involves intravenous administration of enzymes in order to correct the deficiency of enzymes.

Read more @ https://www.coherentmarketinsights.com/market-insight/lysosomal-storage-diseases-therapeutics-market-3651

DYSPHAGIA MANAGEMENT MARKET

Difficulty in swallowing foods or liquids is termed as dysphagia. Dysphagia management involves use of food texture altering products and other products such as tubes to ease the process of swallowing. Dysphagia is caused due to oral, esophageal or oropharyngeal cancer and is more common in patient suffering from stroke.

Read more @ https://www.coherentmarketinsights.com/market-insight/dysphagia-management-market-3612

EUROPE PHARMACEUTICAL DRUGS MARKET

Pharmaceutical drugs are composed of chemical compounds which are used for prevention and treatment of diseases and are administered intravenously, orally, intramuscularly, and other routes of administration. Pharmaceutical drugs are of two types; generic and branded. Pharmaceutical drugs are subjected to numerous regulations with respect to patenting, clinical trial, drug safety, efficacy and marketing in European region.

Read more @ https://www.coherentmarketinsights.com/market-insight/europe-pharmaceutical-drugs-market-3541

Contact Us:
Mr. Shah
Coherent Market Insights
1001 4th Ave.
#3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: sales@coherentmarketinsights.com

View original content:http://www.prnewswire.com/news-releases/colonoscopy-bowel-preparation-drugs-market-to-surpass-us-2-4-billion-globally-by-the-end-of-2027--coherent-market-insights-301027375.html

SOURCE Coherent Market Insights